A Clinical Trial to Study the Efficacy and Safety of Different Doses of Bone Marrow Derived Mesenchymal Stem Cells in Patients With Critical Limb Ischemia Due to Buergers Disease

NCT01484574 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

90

Enrollment

INDUSTRY

Sponsor class

Conditions

Critical Limb Ischemia
Buerger's Disease

Interventions

BIOLOGICAL: Allogeneic Mesenchymal Stem Cells
BIOLOGICAL: Allogeneic Mesenchymal Stem Cells

Sponsor

Stempeutics Research Pvt Ltd